Wuxi Biologics CaymanWXIBF
13F holders, Q1 2024 (March 31)1holders
$1.83avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Wuxi Biologics Cayman Inc. (WXIBF) in their 13F filings. The largest holder was Boston Common Asset Management, LLC ($1.6M).
- Company
- Wuxi Biologics Cayman Inc.
- CUSIP
- G97008117
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Boston Common Asset Management, LLC | 0.04% | Add +50.5% | 869,000 | $1.6M |
"% of holder's portfolio" is WXIBF's weight in each manager's 13F, not the share of Wuxi Biologics Cayman Inc. the manager owns.